Will Pfizer up its offer for AstraZeneca?

4:38 AM ET Mon, 19 May 2014

Savvas Neophytou, pharmaceutical analyst at Panmure Gordon, says the probability of any further move from Pfizer on AstraZeneca has been greatly reduced as both groups disagree on the value of AstraZeneca's pipeline.